Supriya Lifescience

Supriya Lifescience Dividend per Share

The Dividend per Share of Supriya Lifescience (SUPRIYA.NS) as of Oct 16, 2026 is 1.00 INR. In the previous year, Dividend per Share was 0.80 INR — a change of 25.00% (higher).

Dividend per Share

1.00INR

YoY

25.00%

Last updated:

Dividend per Share of Supriya Lifescience is 2025 1.00 INR. Dividend per Share of Supriya Lifescience was 2024 0.80 INR. It decreases by 25.00% higher compared to the previous year.

Supriya Lifescience currently offers a dividend yield of about 0.11%. The payout ratio is around 5% of earnings. The dividend has grown at 13.6% per year over the past 4 years.

The Supriya Lifescience Dividend per Share history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Dividend per Share
Date
Dividend per Share
Jan 1, 2022
0.60 INR
Jan 1, 2023
0.60 INR
Jan 1, 2024
0.80 INR
Jan 1, 2025
1.00 INR
Jan 1, 2026
1.00 INR
Jan 1, 2027 (e)
1.19 INR
Jan 1, 2028 (e)
1.41 INR
Jan 1, 2029 (e)
1.67 INR
The Supriya Lifescience Dividend per Share history
YEARDividend per ShareYoY
est1.67INR+18.56%
est1.41INR+18.56%
est1.19INR+18.56%
1.00INR0.00%
1.00INR+25.00%
0.80INR+33.33%
0.60INR0.00%
0.60INR—
0.00INR—
0.00INR—
0.00INR—
0.00INR—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Supriya Lifescience Stock analysis

What does Supriya Lifescience do? Supriya Lifescience Ltd is a pharmaceutical company based in Mumbai, India, operating within the healthcare sector. The company specializes in the research, development, and manufacturing of active pharmaceutical ingredients (APIs), with a focus on niche therapeutic segments. It employs 392 full-time staff and completed its initial public offering (IPO) on December 28, 2021. The firm's manufacturing facilities are located in Maharashtra, and it exports products to approximately 86 countries. Its product portfolio includes APIs for antihistamines, anesthetics, anti-asthma treatments, and other therapeutic areas such as analgesics and vitamins. Specific products mentioned include Chlorphenamine Maleate, Pheniramine Maleate, Brompheniramine Maleate, Dexchlorpheniramine Maleate, Mepyramine / Pyrilamine Maleate, Dexbrompheniramine Maleate, Cetirizine DiHCL, Diphenhydramine HCL, Bisoprolol Fumarate, Nicorandil, Mecobalamin, Hydroxocobalamin Sulphate, Hydroxocobalamin Acetate, and Hydroxocobalamin Hydrochloride. The company is engaged in the production of bulk drugs and pharmaceutical chemicals, serving global markets through its export activities. It operates with a focus on niche API products, addressing specific therapeutic needs across multiple categories. The company's website is https://supriyalifescience.com/. Supriya Lifescience is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Supriya Lifescience stock

Dividend per Share of Supriya Lifescience is 1.00 INR in 2025.

Dividend per Share of Supriya Lifescience changed from 0.80 INR to 1.00 INR, representing a 25.00% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Dividend per Share Supriya Lifescience since 2006 – with annual values, charts, and detailed analysis.

Dividend per share is the total dividend payment divided by shares outstanding. It shows how much cash each share receives in dividends.

Dividend per Share's INR is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Dividend per Share's Supriya Lifescience historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Dividend — Supriya Lifescience

DividendDividend YieldDividend per ShareYears Dividend PaidYears Dividend Not DecreasedYears Dividend IncreasedDividend Coverage

All Key Metrics — Supriya Lifescience